PMC:7195088 / 23404-23631 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T115","span":{"begin":158,"end":166},"obj":"Disease"}],"attributes":[{"id":"A115","pred":"mondo_id","subj":"T115","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ary endpoint: clinical cure (follow-up 3 months).\n• Comparison of oseltamivir plus chloroquine vs. oseltamivir plus lopinavir/ritonavir in patients with mild COVID-19 and of lopinavir/ritonavir plus oseltamivir vs. darunavir/ri"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T280","span":{"begin":66,"end":77},"obj":"Chemical"},{"id":"T281","span":{"begin":83,"end":94},"obj":"Chemical"},{"id":"T282","span":{"begin":99,"end":110},"obj":"Chemical"},{"id":"T283","span":{"begin":116,"end":135},"obj":"Chemical"},{"id":"T284","span":{"begin":116,"end":125},"obj":"Chemical"},{"id":"T285","span":{"begin":126,"end":135},"obj":"Chemical"},{"id":"T286","span":{"begin":174,"end":193},"obj":"Chemical"},{"id":"T287","span":{"begin":174,"end":183},"obj":"Chemical"},{"id":"T288","span":{"begin":184,"end":193},"obj":"Chemical"},{"id":"T289","span":{"begin":199,"end":210},"obj":"Chemical"},{"id":"T290","span":{"begin":215,"end":224},"obj":"Chemical"}],"attributes":[{"id":"A280","pred":"chebi_id","subj":"T280","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"},{"id":"A281","pred":"chebi_id","subj":"T281","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"},{"id":"A282","pred":"chebi_id","subj":"T282","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"},{"id":"A283","pred":"chebi_id","subj":"T283","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A284","pred":"chebi_id","subj":"T284","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A285","pred":"chebi_id","subj":"T285","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A286","pred":"chebi_id","subj":"T286","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A287","pred":"chebi_id","subj":"T287","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A288","pred":"chebi_id","subj":"T288","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A289","pred":"chebi_id","subj":"T289","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"},{"id":"A290","pred":"chebi_id","subj":"T290","obj":"http://purl.obolibrary.org/obo/CHEBI_367163"}],"text":"ary endpoint: clinical cure (follow-up 3 months).\n• Comparison of oseltamivir plus chloroquine vs. oseltamivir plus lopinavir/ritonavir in patients with mild COVID-19 and of lopinavir/ritonavir plus oseltamivir vs. darunavir/ri"}